SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-287652
Filing Date
2022-11-17
Accepted
2022-11-17 16:04:20
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d418043d424b5.htm 424B5 394354
2 GRAPHIC g418043g00g06.jpg GRAPHIC 62477
3 GRAPHIC g418043g00g51.jpg GRAPHIC 91672
4 GRAPHIC g418043g80c80.jpg GRAPHIC 93416
  Complete submission text file 0001193125-22-287652.txt   736961
Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-257640 | Film No.: 221398337
SIC: 2834 Pharmaceutical Preparations